Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population
- PMID: 21535891
- PMCID: PMC3114786
- DOI: 10.1186/1476-4598-10-48
Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population
Abstract
Background: Undifferentiated nasopharyngeal carcinoma (NPC) is strongly related to Epstein-Barr virus (EBV) infection, allowing aberrant antibodies against EBV and viral DNA load as screening tools in high risk populations. Methylation analysis in the promoter of tumor suppressor genes (TSGs) may serve as a complementary marker for identifying early cases. This study determined methylation status of multiple TSGs and evaluated whether it may improve early detection.
Methods: Nasopharyngeal brushings were taken from 53 NPC patients, 22 high risk subjects and 25 healthy EBV carriers. Corresponding NPC paraffin tissue was included. DNA was bisulfite-modified preceding analysis by methylation-specific PCR (MSP). Ten TSGs were studied.
Results: NPC paraffin and brushing DNA revealed an 81.8% concordance so that MSP analysis was done using either one of both specimens. NPC samples showed methylation for individual TSGs (DAPK1 79.2%, CDH13 77.4%, DLC1 76.9%, RASSF1A 75.5%, CADM1 69.8%, p16 66.0%, WIF1 61.2%, CHFR 58.5%, RIZ1 56.6% and RASSF2A 29.2%). High risk individuals, having elevated EBV IgA and viral load, showed high frequency of methylation of CDH13, DAPK1, DLC1 and CADM1, but low frequency of methylation of p16 and WIF1 and undetectable methylation of RASSF1A, CHFR, RIZ1 and RASSF2A. Healthy subjects showed similar patterns as high risk individuals. A combination of RASSF1A and p16 gave good discrimination between NPC and non-NPC, but best results were combined analysis of five methylation markers (RASSF1A, p16, WIF1, CHFR and RIZ1) with detection rate of 98%.
Conclusion: Multiple marker MSP is proposed as a complementary test for NPC risk assessment in combination with EBV-based markers.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3114786/bin/1476-4598-10-48-1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3114786/bin/1476-4598-10-48-2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3114786/bin/1476-4598-10-48-3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3114786/bin/1476-4598-10-48-4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3114786/bin/1476-4598-10-48-5.gif)
Similar articles
-
Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.Int J Cancer. 2015 Feb 15;136(4):E127-35. doi: 10.1002/ijc.29192. Epub 2014 Sep 19. Int J Cancer. 2015. PMID: 25196065
-
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.Int J Cancer. 2017 Jan 1;140(1):149-162. doi: 10.1002/ijc.30418. Epub 2016 Sep 23. Int J Cancer. 2017. PMID: 27600027 Free PMC article.
-
Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.Cancer Sci. 2020 Feb;111(2):592-600. doi: 10.1111/cas.14281. Epub 2020 Feb 5. Cancer Sci. 2020. PMID: 31834989 Free PMC article.
-
Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.EBioMedicine. 2017 Apr;18:32-40. doi: 10.1016/j.ebiom.2017.03.038. Epub 2017 Apr 2. EBioMedicine. 2017. PMID: 28396012 Free PMC article. Review.
-
Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.Methods Mol Biol. 2020;2204:99-107. doi: 10.1007/978-1-0716-0904-0_9. Methods Mol Biol. 2020. PMID: 32710318 Review.
Cited by
-
EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma.Clin Epigenetics. 2024 Jan 11;16(1):11. doi: 10.1186/s13148-024-01624-y. Clin Epigenetics. 2024. PMID: 38212818 Free PMC article.
-
Diagnostic Value of DAPK Methylation for Nasopharyngeal Carcinoma: Meta-Analysis.Diagnostics (Basel). 2023 Sep 12;13(18):2926. doi: 10.3390/diagnostics13182926. Diagnostics (Basel). 2023. PMID: 37761293 Free PMC article.
-
The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers.Cancers (Basel). 2023 May 17;15(10):2801. doi: 10.3390/cancers15102801. Cancers (Basel). 2023. PMID: 37345137 Free PMC article. Review.
-
Predicting Radioresistant Biomarkers in Nasopharyngeal Carcinoma Patients Via Protein-Protein Interaction Network Analysis.J Lasers Med Sci. 2021 Dec 1;12:e76. doi: 10.34172/jlms.2021.76. eCollection 2021. J Lasers Med Sci. 2021. PMID: 35155161 Free PMC article.
-
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma.Cancer Manag Res. 2021 Sep 21;13:7311-7323. doi: 10.2147/CMAR.S317319. eCollection 2021. Cancer Manag Res. 2021. PMID: 34584457 Free PMC article.
References
-
- Soeripto. Epidemiology of nasopharyngeal carcinoma. Berita Kedokteran Masyarakat (Ina) 1998;XIII:207–211.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous